Craft

NeurAxis

Stock Price

$3.1

2024-09-12

Market Capitalization

$21.2 M

2024-09-12

Revenue

$2.5 M

FY, 2023

NeurAxis Summary

Company Summary

Overview
NeurAxis (formerly known as Innovative Health Solutions) is a company that develops medical devices to reduce the symptoms of opioid withdrawal. It offers percutaneous electrical nerve field stimulation (PENFS) technology for advancing the science in the field of multiple pediatric diseases. The company also provides IB-Stim, a PENFS system intended to be used in patients with functional abdominal pain associated with IBS.
Type
Public
Status
Active
Founded
2011
HQ
Carmel, IN, US | view all locations
Website
https://neuraxis.com/
Cybersecurity rating
Sectors

Key People

  • Brian Carrico

    Brian Carrico, President & Chief Executive Officer

  • Dan Clarence

    Dan Clarence, Chief Operating Officer

  • Tom Carrico, Chief Regulatory Officer

  • John G. Seale

    John G. Seale, Treasurer & Chief Financial Officer

    LocationsView all

    1 location detected

    • Carmel, IN HQ

      United States

      11550 N Meridian St Suite 325

    NeurAxis Financials

    Summary Financials

    Revenue (Q2, 2024)
    $611.5K
    Gross profit (Q2, 2024)
    $538.0K
    Net income (Q2, 2024)
    ($2.9M)
    Cash (Q2, 2024)
    $1.8M
    EBIT (Q2, 2024)
    ($2.2M)
    Enterprise value
    $24.7M

    Footer menu